Key result
Homozygous CD36 Y325 variant linked to ~4.8-fold higher DCM risk in African ancestry individuals.
Why the study?
Dilated cardiomyopathy disproportionately affects individuals of African ancestry with more pronounced familial clustering, and the contribution of a common CD36 variant relative to TTN truncating variants and other genes was unclear.
Does the CD36 Y325 nonsense variant alter the risk of dilated cardiomyopathy in individuals of predominantly African ancestry?
Observational (n=82,623)
Yes
Does the CD36 Y325 nonsense variant alter the risk of dilated cardiomyopathy in individuals of predominantly African ancestry?
An ancestry-specific CD36 variant (Y325) contributes a higher population attributable fraction to the burden of dilated cardiomyopathy among individuals of African ancestry than established monogenic causes like TTN truncating variants.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The amount of risk for dilated cardiomyopathy in people of African ancestry that's accounted for by this one genetic variant is at least as much as is accounted for by major risk factors like diabetes or chronic kidney disease. While further work is needed to define the exact ways in which these findings will impact practice, they should meaningfully inform clinical suspicion and diagnostic evaluation for patients with African ancestry and heart failure.”
“This discovery demonstrates the power of large-scale genomic and clinical data from diverse populations to identify high-impact and potentially actionable mechanisms of disease. By defining a pathway to dilated cardiomyopathy in which the heart's ability to use fuel efficiently is impaired, we are laying the groundwork for new approaches to precision prevention and treatment.”
May inform ancestry-specific DCM evaluation; challenges TTN dominance in African ancestry but leaves open prospective validation.
Importance Dilated cardiomyopathy (DCM) is a major cause of heart failure that disproportionately affects individuals of predominantly African ancestry, among whom familial clustering of disease is more pronounced relative to those of predominantly European ancestry. Truncating variants in TTN , which encodes the sarcomeric protein titin, are the most common established monogenic cause of DCM. A common CD36 nonsense variant enriched among individuals of African ancestry has also been shown to account for a substantial burden of DCM. Objective To compare the contribution of a CD36 nonsense variant to DCM risk with that of truncating variants in TTN and pathogenic or likely pathogenic variants in other established genes for DCM. Design, Setting, and Participants Multicohort genetic association study including participants of African and European ancestry with exome or genome sequence data and DCM case status from the following 4 US datasets: All of Us Research Program (recruitment: 2017-present; last follow-up: August 27, 2024), Million Veteran Program (recruitment: 2011-present; last follow-up: September 30, 2024), Penn Medicine Biobank (recruitment: 2013-present; last follow-up: November 14, 2022), and the DCM Precision Medicine Study (recruitment: 2016-2020; last follow-up: March 15, 2020). Exposure Carrier status for TTN truncating variants, pathogenic or likely pathogenic variants in 11 high-confidence genes for DCM, and the nonsense variant CD36 Y325* (0, 1, or 2 copies). Main Outcomes and Measures Risk of DCM, prevalence of variant carriers among DCM cases, and population attributable fraction of DCM. Results Among 82 623 individuals of predominantly African ancestry across 4 cohorts, the mean age was 53.4 years (SD, 13.9 years), 47 124 were male, and 1316 had DCM. Individuals who were homozygous for the CD36 Y325* risk allele had a higher risk of DCM (odds ratio [OR], 4.8; 95% CI, 3.1-7.3) as did those who were heterozygous (OR, 1.4; 95% CI, 1.2-1.7). TTN truncating variants also conferred an elevated risk of DCM in participants of African ancestry (OR, 8.5; 95% CI, 5.5-13.0). Among 1316 individuals of African ancestry classified as DCM cases, 33 (2.5%) were homozygous for CD36 , 56 (4.3%) had TTN truncating variants, and 16 (1.2%) had pathogenic or likely pathogenic variants in other high-confidence genes for DCM. In population-level analyses incorporating both heterozygous and homozygous CD36 Y325* carriers, the population attributable fraction for CD36 (9.0% [6.2% for heterozygous carriers and 2.8% for homozygous carriers]) surpassed the population attributable fraction for TTN truncating variants (3.7%). Conclusions and Relevance In 4 US cohorts, an ancestry-specific CD36 variant contributed more to DCM burden among individuals of African ancestry than established genes for DCM, including TTN truncating variants that are typically considered the most common genetic cause. These findings reshape the known genetic architecture of DCM in individuals of African ancestry and highlight the importance of representation in genomic research.
No takes yet. Share an insight, caveat, or question.
Challa et al. (2026) conducted an observational in Dilated cardiomyopathy (n=82,623). CD36 Y325 nonsense variant carrier status vs. Non-carriers was evaluated on Risk of dilated cardiomyopathy (OR 4.8, 95% CI 3.1-7.3). Homozygosity for the CD36 Y325 nonsense variant increased the risk of dilated cardiomyopathy among individuals of African ancestry.
Synapse has enriched 10 related papers. Consider them for comparative context: